Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35F5 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc35f5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC35F5 mRNA | CTD | PMID:36331819 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | o and p'-DDT results in increased expression of SLC35F5 mRNA | CTD | PMID:18204070 | 1,2-dimethylhydrazine | decreases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SLC35F5 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of SLC35F5 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc35f5 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC35F5 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC35F5 mRNA | CTD | PMID:16214954 and PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35F5 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC35F5 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC35F5 mRNA | CTD | PMID:18796159 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of SLC35F5 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SLC35F5 mRNA | CTD | PMID:30851411 | 5-fluorouracil | affects response to substance | ISO | SLC35F5 (Homo sapiens) | 6480464 | SLC35F5 protein affects the susceptibility to Fluorouracil | CTD | PMID:16477629 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SLC35F5 mRNA | CTD | PMID:24780913 | acrolein | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC35F5 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC35F5 mRNA | CTD | PMID:32699268 | aflatoxin B1 | decreases methylation | ISO | SLC35F5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SLC35F5 gene | CTD | PMID:27153756 | alpha-pinene | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC35F5 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC35F5 mRNA | CTD | PMID:32699268 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of SLC35F5 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SLC35F5 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC35F5 mRNA | CTD | PMID:21569818 and PMID:27195522 | benzo[a]pyrene | decreases methylation | ISO | Slc35f5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of SLC35F5 exon and Benzo(a)pyrene results in decreased methylation of SLC35F5 intron | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC35F5 mRNA | CTD | PMID:33296240 and PMID:34947998 | bisphenol A | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLC35F5 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC35F5 mRNA | CTD | PMID:32145629 | butanal | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of SLC35F5 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC35F5 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC35F5 mRNA | CTD | PMID:35301059 | chlorpyrifos | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SLC35F5 mRNA | CTD | PMID:37019170 | crocidolite asbestos | decreases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of SLC35F5 mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC35F5 mRNA | CTD | PMID:27989131 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SLC35F5 mRNA | CTD | PMID:29391264 | formaldehyde | increases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SLC35F5 mRNA | CTD | PMID:23649840 | inulin | multiple interactions | ISO | Slc35f5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC35F5 mRNA | CTD | PMID:36331819 | methyl methanesulfonate | increases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SLC35F5 mRNA | CTD | PMID:23649840 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of SLC35F5 gene | CTD | PMID:33148267 | ozone | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC35F5 mRNA more ... | CTD | PMID:32699268 | paracetamol | affects expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLC35F5 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLC35F5 mRNA | CTD | PMID:21420995 | pentachlorophenol | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of SLC35F5 mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc35f5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC35F5 mRNA more ... | CTD | PMID:36331819 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of SLC35F5 gene | CTD | PMID:33148267 | pirinixic acid | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SLC35F5 mRNA | CTD | PMID:17426115 and PMID:23811191 | potassium chromate | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SLC35F5 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35F5 mRNA | CTD | PMID:22079256 | quercetin | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SLC35F5 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SLC35F5 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | SLC35F5 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC35F5 mRNA | CTD | PMID:23557933 | temozolomide | decreases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of SLC35F5 mRNA | CTD | PMID:31758290 | tetrachloromethane | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SLC35F5 mRNA | CTD | PMID:27339419 and PMID:31919559 | thapsigargin | decreases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of SLC35F5 protein | CTD | PMID:24648495 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SLC35F5 mRNA | CTD | PMID:34492290 | tungsten | increases expression | ISO | Slc35f5 (Mus musculus) | 6480464 | Tungsten results in increased expression of SLC35F5 mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Urethane results in increased expression of SLC35F5 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLC35F5 mRNA | CTD | PMID:25979313 | valproic acid | decreases methylation | ISO | SLC35F5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SLC35F5 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | SLC35F5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC35F5 mRNA | CTD | PMID:28001369 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of SLC35F5 gene | CTD | PMID:31682807 | |